Absolem allies with AREV to grow into top mushroom extraction soln

By Nikita Chaurasia  Date: 2019-11-29

Absolem allies with AREV to grow into top mushroom extraction soln

Absolem Extractions, a subsidiary of Absolem Health, recently signed a definitive deal with AREV. The deal is expected to position Absolem as the leading solution for functional extraction of mushrooms. For the uninitiated, AREV delivers and creates functional ingredients and compounds, while Absolem offers extractions for the functional food market, particularly in mushrooms.

Speaking on the development, Ken Kuiper, CEO, Absolem, said that the company is thrilled about the expanding global interest in functional mushrooms. The company feels that it has the potential to become the best commercial extraction unit in the market, and AREV’s extensive knowledge in extractions could majorly help Absolem reach its peak.

Michael Withrow, CEO, AREV, meanwhile said that Absolem’s team has identified huge growth in natural medicines. Their company is pleased to be a part of this innovation and hopes that this partnership would lead to the production of another line of formulations and branded ingredients, contributing towards strengthening its revenue stream.

Reportedly, Absolem Health has also finalized the purchase of One Up Pure Energy, a beverage and food line of functional mushroom powders, snacks, teas, and mushroom-based meat alternative protein items.

Prior to this, the Yield Growth Corp. had made its entry into the edible mushroom market when its subsidiary, Flourish Mushroom Labs Inc. inked a deal to acquire 9 recipes that include edible mushrooms as an important ingredient.

According to reliable sources, the recipes come from various creators which include, a holistic health coach and food chemist, a chef and a chemical engineer. Moreover, the deal was expected to be finalized under 30 days.

Yield Growth has also agreed to purchase 30% of Absolem Health Corp. (owner of One Up Pure Energy). For the uninitiated, Absolem Health holds Health Canada approval for edible mushroom snacks.

As for Absolem Extractions and AREV deal, details regarding to the terms of the agreement will be announced when the transaction is finalized. However, it would be subject to the approval of the CSE.

Source Credit: https://www.nutraceuticalbusinessreview.com/news/article_page/Absolem_enters_mushroom_extraction_joint_venture/160416

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...